« INDUSTRY NEWS
Completing his term on the DCAT Advisory Council was Joseph Principe, vice president, business development, North America, Patheon. Mr. Principe served as the association’s president in 2009-2010.
Gerresheimer Pays Tribute to Employees Celebrating Jubilees
11,000 people work at the 47 Gerresheimer sites around the world. 115 loyal employees who have been with the company for 10 years and in some cases much longer celebrated their jubilees this year at the German sites. Herbert Muntanjohl tops the list with 50 years of service at Gerresheimer Medical Plastic Systems and the predecessor company.
“We’re delighted that so many of our employees have been with us for so many years, and it shows how satisfi ed they are with us as their employer,“ said Thomas Perlitz, Director HR. It is also confi rmation of the success of the company’s HR policy at its sites throughout Germany. Gerresheimer has a total of 3,250 employees in Bünde, Düsseldorf, Essen, Lohr, Pfreimd, Meiningen, Tettau, Wackersdorf and Wertheim. At its other sites around the world, the employees in the Gerresheimer workforce have an average of eleven years of service, which is pretty impressive. The average age of all 11,000 employees is around 40.
There are 12 employees among the 115 people celebrating their jubilees, the majority of whom have been with the company for more than 20 years, who have been working at Gerresheimer for 40 years. The longest serving employee this year is Herbert Muntanjohl, who joined the company 50 years ago when he started out as an apprentice. In eight months’ time, the lathe operator will be taking well-earned retirement.
New Release of Accelrys Materials Studio Boosts Value of Modeling and Simulation in Scientifi c Innovation
Accelrys, Inc., a leading provider of scientifi c innovation lifecycle management solutions, announced the release of the Accelrys Materials Studio® 7.0 modeling and simulation environment for chemists, polymer scientists and other materials scientists. The latest release contains enhancements in quantum mechanics, classical simulation, usability, visualization and collaboration, enabling scientists to engineer better performing and more cost- eff ective materials across a wide range of applications including pharmaceuticals, catalysts, polymers, composites, metals, alloys, batteries, fuel cells and more.
Accelrys Materials Studio 7.0 also extends computational science across more people by enabling project teams to model and evaluate materials performance and behavior using best-practice protocols developed by computational experts and shared with
project teams across all stages of the scientifi c innovation lifecycle, from lab to commercialization. Studies have shown that the use of advanced modeling and simulation software can greatly reduce the number of experiments required to introduce new materials while also improving return on investment and time to market.
“Accelrys Materials Studio 7.0 delivers more science and more applications to more people,” said Leif Pedersen, senior vice president, marketing, product management and corporate development, Accelrys. “New scientifi c capabilities and productivity improvements in the latest release of Accelrys’ industry-leading materials modeling and simulation software will help scientists screen more materials faster, with greater accuracy and less eff ort, saving time and resources while accelerating innovation across a broad range of consumer and commercial products.”
Accelrys Materials Studio 7.0 provides best-in-class, multi-scale modeling in a single unifi ed environment.
Strategic Alliance Provides a Bright Future
ABITEC has learned how to make great things happen with limited resources and a sharing culture, by forging expert alliances. The company is working with Professor Abu Serajuddin, an internationally renowned pharmaceutical specialist from the College of Pharmacy and Allied Health Professionals at St. John’s University in New York. Professor Serajuddin has a distinguished pedigree supported by over ten patents, many years in industry with market leaders like Bristol Myers and Novartis and over 70 peer-reviewed published research papers. Together with ABITEC and his team of Master and Ph.D. students, Dr. Serajuddin pioneers studies focusing on basic and applied research using ABITEC’s functional lipid excipients for drug solubilisation and delivery.
“This kind of partnership gives us access to basic science that we did not have the internal resources to commit to. By combining our expertise in this way we are providing real solutions to the pharmaceutical market, expanding our trustworthy reputation and ultimately building our brand. We have already had two peer- reviewed articles published by Dr. Serajuddin and co-authored by Damon Dalrymple. We look at the long view of trends in drug formulization and delivery and help direct research that will solve problems for our industrial partners,” explains Global Business Director, Dr. Donald Kelemen.
The ABITEC strategic alliance is focusing on key areas such as providing soluble forms of drugs for research so they can be scientifi cally assessed for toxicology and effi cacy and improved delivery systems for existing drugs with issues around bio compatibility and eff ective dosage.
The time, money and expertise that ABITEC invests in
supporting the graduate students in its partnership program are long term investments that pay dividends on many levels.
www.americanpharmaceuticalreview.com | | 85
»
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92